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A B S T R A C T
Introduction. Treatment with pelvic external beam radiotherapy with brachytherapy (EBRT/BT) for gynecological
cancers may cause sexual dysfunction because of vaginal shortening and tightening. Regular vaginal dilator use is
thought to reduce vaginal shortening and/or tightening, but compliance is poor.
Aims. This study identified determinants of patients’ adherence with dilator use after EBRT/BT.
Methods. Semi-structured interviews were conducted with 30 women, aged 32–67 years, treated with EBRT/BT for
gynecological cancers at two university medical centers in the past 36 months. Transcriptions were coded and
analyzed with N-Vivo software.
Main Outcome Measures. Determinants of dilator use were clustered based on the Health Action Process Approach,
which describes (i) motivation processes that lead to a behavioral intention and (ii) volition processes that lead to the
initiation or maintenance of actual behavior.
Results. Almost all women attempted to perform long-term regular vaginal dilator use. Intended dilator use was
determined by the expectation that it would prevent the development of vaginal adhesions and stenosis. Planning
dilator use and making it part of a routine, using it under the shower, using lubricants, a smaller dilator size, or
vibrators helped women. Others reported a lack of time or privacy, forgetting, or feeling tired. Women self-regulated
dilator use by rotating the dilator and timing dilator use. Influencing factors were negative emotions regarding
dilator use or its hard plastic design, (being anxious for) pain or blood loss, and an association with EBRT/BT. Some
women mentioned a lack of instrumental support, for example, lubricants. Others received reassurance through
informational support or were supported socially.
Conclusion. Motivation and volition processes that determined dilator use were identified and used in the develop-
ment of a sexual rehabilitation intervention. It is important to provide sufficient patient information and support, and
enlarge patients’ perceived self-efficacy. Bakker RM, Vermeer WM, Creutzberg CL, Mens JWM, Nout RA, and
ter Kuile MM. Qualitative accounts of patients’ determinants of vaginal dilator use after pelvic radiotherapy.
J Sex Med 2015;12:764–773.
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Introduction
T reatment for gynecological cancers maycause sexual dysfunction, especially when
treatment includes pelvic external beam radio-
therapy with brachytherapy (EBRT/BT) [1–7].
The negative effect of treatment with EBRT/BT is
attributed to vaginal shortening and tightening
induced by fibrosis and stenosis [8,9]. Regular
vaginal dilator use is thought to reduce vaginal
shortening and/or tightening [10–12]. Although
more empirical evidence is needed [13], dilator use
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has become established practice worldwide [14–
16]. Gynecological cancer experts in the Nether-
lands have reached consensus in a Delphi panel
consensus process on how vaginal dilation should
be performed.1
Despite the proposed benefits of regular dilator
use, patients have difficulties following the instruc-
tions and compliance is poor [17–21]. In previous
studies, 1% to 35% of the participating gynecologi-
cal cancer patients used a dilator with the recom-
mended frequency within the first 12 months
following EBRT/BT [17,18,20–22]. In two studies,
10 to 15 gynecological cancers patients were inter-
viewed after EBRT/BT about their experiences
with dilator use and reasons for (non)compliance
[23,24]. Reported barriers were painful insertion,
embarrassment, fear, reliving the invasive treat-
ment, lack of information or time, forgetting, or
dilation not being a priority during recovery
[23,24]. Facilitating factors mentioned by patients
were concern about the development of vaginal
adhesions, belief that dilators help, reminders of
adhesion development, acceptance of dilator use as
part of a routine or an extension of treatment, or
focusing on positive aspects of dilator use [23].
Aims
It remains unclear how these barriers and facilita-
tors explain the women’s compliance with dilator
use. Therefore, this qualitative study aimed to
identify the determinants of intention, initiation,
and maintenance of long-term regular dilator use
and to describe dilator use as a health behavioral
process. Moreover, the identified determinants
were supported by the theoretical constructs of the
Health Action Process Approach (HAPA), which




Eligible women (aged 20–70 years) were treated
with EBRT/BT for gynecological cancers at two
university medical centers 2 to 36 months prior
to the interview. Exclusion criteria were signs of
recurrent or metastatic cancer, medical or psycho-
logical problems, living abroad, or insufficient
knowledge of the Dutch language.
Three radiation oncologists informed women
about the study during their follow-up consulta-
tions between November 2012 and July 2013. It
was ascertained that the participants consented to
be interviewed. Participants received a 20-euro
gift voucher. The Leiden University Medical
Center (LUMC) Medical Ethics Committee
approved the study protocol.
Data Collection
Two female researchers (R.M. Bakker and W.M.
Vermeer) conducted semi-structured face-to-face
interviews, in private, either at home or at the
medical center. Two interviews were conducted
by telephone because of practical reasons. The
average duration of the interviews was 42 minutes
(range: 27 to 62 minutes). As psychologists (MSc
and PhD, respectively), the researchers were
trained and experienced in interviewing patients,
and not involved in the treatment of the women.
All interviews were digitally recorded and tran-
scribed verbatim.
Data Analyses
The transcriptions were analyzed with QSR
International’s NVivo 10 software using the
Framework Approach [26,27]. The Framework
Approach is used in health research to systema-
tically analyze qualitative data by applying a
combination of deductive and inductive coding.
Therefore, emerging themes were identified using
an a priori coding scheme based on the interview
topics. The coding of the two researchers was
compared and discussed after every third inter-
view. Agreement on the adequacy of new emerging
codes was achieved through negotiated consensus.
At first, R.M. Bakker and W.M. Vermeer coded a
random sample of 10 interviews. Secondly, R.M.
Bakker coded the remaining 20 interviews using
the definitive coding scheme. Lastly, they coded
and cross-checked five of these interviews to
ensure consensus on the definitive coding scheme
and—if needed—complement the coding (R.M.
Bakker and W.M. Vermeer) [28]. Descriptive sta-
tistics (e.g., age) were calculated using IBM SPSS
version 21 (IBM Corp., Armonk, NY, USA).
Main Outcome Measures
Socio-demographic data were obtained from
both women’s medical records and the interview.
1Experts reached consensus that it is best to use plastic
dilator sets, to start around 4 weeks after EBRT/BT, to
perform dilator use two to three times a week, for 1 to 3
minutes, and to continue for 9 to 12 months. The fre-
quency of dilator use could be lowered each time patients
had sexual intercourse [29].
Patients’ Determinants of Dilator Use after Pelvic Radiotherapy 765
J Sex Med 2015;12:764–773
Participants were interviewed about (i) received
information and support, regarding sexual reha-
bilitation and vaginal dilator use; (ii) experiences
with dilator use; and (iii) reasons for (non)compli-
ance with dilator use. Table 1 describes the inter-
view topics in detail.
The determinants of dilator use reported by the
participants were analyzed using the theoretical
constructs of the HAPA [25]. The HAPA describes
the intention, initiation, and maintenance of
health behaviors as a process. According to the
HAPA, the intention to perform long-term regular
dilator use is influenced by risk perception (the per-
ceived likelihood of vaginal shortening and tight-
ening) and outcome expectancies (the pros and cons
of regular dilator use). Transforming the intention
into initiation and maintenance of dilator use
requires planning (where and when to perform
dilator use and how to cope with possible difficul-
ties), action control (evaluating the ongoing dilator
use), and resources (instrumental, informational, or
social support). Also, for example, negative emo-
tions may form a barrier to perform dilator use.
The perceived self-efficacy (the belief to be able to
perform, continue, and resume dilator use after
relapse) also affects dilator use. See also Figure 1,




At the LUMC, 13 out of 17 (77%) and at the
Erasmus Medical Center 17 out of 35 (49%) eli-
gible women participated (in total 58%). Five
women declined participation because the subject
was too upsetting or intimate, four because of per-
sonal reasons, and two others could not be reached
by phone. The other 11 women declined partici-
pation for unknown reasons (as the women were
not obliged to specify their reason for refusing
participation).
No new themes emerged after interviewing 25
women and thus data saturation was reached [30].
Participants were treated with primary (n = 25) or
postoperative EBRT/BT (n = 5) (together with
chemotherapy in n = 25) for cervical cancer
(n = 29) or vaginal cancer (n = 1). The majority of
the women had squamous cell carcinoma (n = 26)
and a minority adenocarcinoma (n = 4). Further-
more, participants were treated 16 months ago
on average (±standard deviation [SD] = 9, range:
2–36 months). The mean age was 49 years
(±SD = 11, range: 32–67 years). All participants
under the age of 45 years were offered hormone
replacement therapy until they were 50 because of
their treatment-induced postmenopausal status.
Of all participants, 23 participants were partnered
and 20 women reported to be sexually active.
All participants reported sexual problems and
half of the women reported sexual distress since
treatment. Almost all women reported pain during
sexual contact. The majority reported symptoms
of a shortened and/or tightened vagina, vaginal
adhesions, loss of sexual desire, lubrication prob-
lems, a burning sensation and sensitive vaginal
skin, loss of blood after penetration, reduced
sexual enjoyment, and/or fear for sexuality (e.g.,
Table 1 Interview themes and topics*
Themes Topics
Demographic characteristics Relationship, job and housing status, important life events, dates of cancer diagnosis, and
treatment
Sexual rehabilitation since treatment Sexual activity
Received information and support • Received information and support regarding sexual health and vaginal dilator use after
pelvic external beam radiotherapy with brachytherapy
• Satisfaction with and suggestions for information provision and support
Adopted vaginal dilator use • Evaluation of the vaginal dilator use in detail
• Alternative dilator use other than the plastic dilator set
• Partner involvement (if applicable)
• Use of other possible components (e.g., lubricants)
Reasons for (non)compliance • Personal motivation and experiences with dilator use
• Practical, psychological, or physical reasons for (non)compliance
• Role of received instructions
• Experienced effect of (non)compliance
• Experienced effect of alternative dilator use
• Effect of experiences with treatment on dilator use
• Experiences with the design of the plastic dilator set
• Role of the partner (if applicable)
• Applicability of other possible components (e.g., lubricants)
*The order and relevance of the topics discussed could vary because of the semi-structured nature of the interview.
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because of possible pain or infections). Also, one-
third reported loss of sexual satisfaction.
Reported Dilator Use
Two women treated more than 2 years ago never
intended to perform dilator use. All other partici-
pants reported to have (had) the intention to use a
dilator and also used a dilator at least once. Fur-
thermore, almost half of the participants per-
formed dilator use at least two times a week. Half
of those women, a quarter of all participants, were
treated at 9 to 12 months previously and com-
pleted the instructed period of use.
However, the other half of the participants were
not able to translate their intention and attempts
in dilator use as recommended. Some of these
women reported dilating regularly only during the
first few months after treatment. Others per-
formed dilator use infrequently or attempted not
more than a few times. The majority was treated
between 1 and 2 years previously.
Determinants of the Intention to Perform Dilator Use
Table 2 provides example quotes of the findings
structured according to the HAPA.
Risk Perception
For most women, the intention to start or con-
tinue dilator use was determined by a motivation
to prevent the development of vaginal adhesions
and subsequent possible occlusion of the vagina
(Quote 1, Table 2). Furthermore, half of the
women became motivated and convinced that
they were at risk of adhesions because they were
bothered or scared to notice that adhesions had
formed. Some already noticed adhesions before
they ever used a dilator and others noticed adhe-
sions after infrequent or lack of dilator use. Some
of the women stated that dilator use was not a
priority because sexuality was irrelevant at that
moment.
Participants’ risk perception was influenced by
the way they perceived the instructions from their
health care providers. The two women who never
intended to perform dilator use reported insuffi-
cient information provision. One of them received
some information, but no dilator set or instruc-
tions. She thought her doctor estimated it was
not necessary. Another woman refused a dilator
set at the time because she thought it was advised
to stimulate sexual contact, which she did not
Outcome 
expectancies: 
Regular dilator use 
helps against the 
vaginal adhesions or 
stenosis 
Intention  
to perform long-term 
regular dilator use 
Planning: 






I monitor how long I perform dilator use 




Regular long-term dilator use 
Negative emotions: 














 (Lack of) Resources, e.g. social support: 
My partner encouraged me to regularly perform dilator use  
DETERMINANTS OF INTENTION DETERMINANTS OF INITIATION & MAINTENANCE
Risk perception: 
I am at risk of 
vaginal adhesions or 
stenosis after pelvic 
radiotherapy  
Self-efficacy: 
I am not capable of making dilator use part of a routine 
Figure 1 Example determinants of vaginal dilator use and their interrelations according to the Health Action Process
Approach.
Patients’ Determinants of Dilator Use after Pelvic Radiotherapy 767
J Sex Med 2015;12:764–773
consider necessary. Furthermore, some women
mentioned to have stopped dilator use after a
while, even though this was not recommended or
approved for by their health care provider. They
hoped that they performed dilator use long
enough to prevent adhesions.
Outcome Expectancies
Participants generally expected that dilator use
would prevent the development of vaginal adhe-
sions and would keep the vagina accessible after
EBRT/BT (Quote 2, Table 2). Also, half of the
women expected to facilitate sexual contact or
intercourse, now or in the future. A couple of
women intended to facilitate physical examination
during posttreatment follow-up appointments.
For one woman, facilitating follow-up examina-
tions was the only well-known purpose to her.
Some women acknowledged continuing dilator
use just because they received the instruction that
it was important or because they saw it as part of
their treatment.
Discovering adhesions after a short period of
not using dilators not only heightened women’s
risk perception but also convinced them of its ben-
eficial effect against adhesions. Some women also
indicated being supported by experiencing ben-
efits like reduction in vaginal tightening and
pain, and an increase in vaginal sensations. A few
women also experienced these beneficial effects
while having sexual intercourse. Retrospectively,
however, participants that adhered to long-term
regular dilator use did not mention to be more
sexually active or satisfied, or have a sexual rela-
tionship more often.
Some women attempting regular dilator use
stated that it did not prevent adhesions or even
caused pain. Half of the women mentioned expe-
riencing pain during dilator use and some reported
blood loss or vaginal discharge. Experiencing pain
or blood loss during dilator use motivated a few
women to continue dilator use, because that would
reduce anxiety and pain.
About half of the women indicated that their
doctor evaluated their vaginal dilator use. A couple
of women became convinced that dilator use was
useful because the doctor told them that the con-
dition of their vagina looked good and accessible
Table 2 Interview topics and example quotes of vaginal dilator use determinants
Topic Example quote
The intention
Risk perception 1 Partnered, 32 – If you don’t insert anything in your vagina when it is one big wound [after treatment], it will
just completely occlude.
Outcome expectancies 2 Partnered, 50 – I feel that I have to do it [referring to dilator use], so it’s not enjoyable, but it is important
I think. Otherwise my vagina gets too small I think.
The initiation and maintenance
Planning 3 Partnered, 53 – Well, I just take a shower and perform dilator use every Tuesday and Friday. Just regular
days and then I take the dilator and just insert it.
Action control 4 Single, 62 – Well, I perform . . . Yes, it’s weird, but I perform dilator use while listening to music from
Wagner. Because it is a music piece that lasts exactly 10 minutes.
Negative emotions
Anxious for pain or
blood loss
5 Partnered, 41 – And because of the radiotherapy I had some burning feeling, some kind of burns, also





6 Partnered, 48 – The idea repulsed me a little. Well maybe because, just after that operation and
brachytherapy and such, the medical world frequently inserted all kinds of objects [referring to vaginally],
and that made you feel like: not now.
Bothersome chore 7 Partnered, 44 – I think it’s odd to have something in and out of your vagina every day. I don’t know. I can’t
explain really. It’s like an extra chore. A bothersome job.
Resources
Instrumental support 8 Partnered, 41 – Those things [referring to dilators] aren’t enjoyable sex toys. [. . .] Then I think: then you
also have to pay for them as well. [. . .] I also let them know that I found that very disturbing.
Informational support 9 Partnered, 36, actor – But it was also kind of scary [referring to blood loss during dilator use], then I heard
from my doctor that . . . “Look, I understand that you have a negative association with blood loss, but it is
understandable that you have it.” That did reassure me.
Social support 10 Partnered, 32 – It was just something I did [referring to dilator use] [. . .] And my partner helped me a lot
and the doctor says: “Use it as often as you can and if it hurts a little . . .” He was really coaching me like:
try to keep it up.
Perceived self-efficacy
11 Partnered, 49 – Because it is some kind of obligation, it’s not . . . That you have to continue as a routine.
I just couldn’t do it . . . I couldn’t get it done in the beginning; I just didn’t know how to handle it.
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after examination. Others had become less con-
vinced because their doctors did not talk about it
or because physical examination was still painful.
Determinants of the Initiation and Maintenance of
Dilator Use
Planning
A group of women explained that planning dilator
use and making it part of a routine helped them to
transform their intention into action (Quote 3,
Table 2). A few women mentioned choosing a
fixed time or day. Someone recommended starting
dilator use shortly after treatment to make it less of
an obstacle. However, some women found it diffi-
cult to make time for dilator use and cleaning
afterward. A couple of women reported forgetting,
being tired, or finding the privacy for dilator use as
a problem.
To anticipate on difficulties during dilator use,
some women lay down on their bed, made sure not
to be disturbed, or playing relaxing music to relax.
About half of the women used neutral (water- or
silicone-based) lubricants during dilator use and
some experienced less discomfort because of it.
Other women used a dilator under the shower to
save lubricant and time. And some women found it
helpful to build up in dilator size in order to reduce
anxiety. A few women placed the dilator against
the vaginal opening or waited before pushing it
inside to get used to the device.
A couple of women preferred using a vibrator,
because they expected it to be more enjoyable, less
alien, and possible to integrate during sexual
contact. However, a few older women could not
even imagine it to be more enjoyable. A couple of
women stopped using a vibrator because they read
that the material could cause cancer or it con-
fronted them with a lack of sexual desire. A couple
of partnered women reported being helped by
making dilator use as part of sexual contact. About
half of the women frequently had sexual inter-
course as an alternative means of dilation and
could therefore lessen (or even stop) dilator use.
However, another few felt pressured by their
partner to have intercourse instead.
Action Control
A few women indicated to rotate the dilator while
inserted in order to better prevent the formation
of adhesions. A few others indicated being helped
by reading something or trying to stop thinking
about daily concerns to be able to continue.
Almost half of the participants inserted a dilator
during 1 to 5 minutes and some women during 10
minutes. A few women mentioned timing the
insertion of dilator use by looking at their watch
or listening to a music piece of a certain length
(Quote 4, Table 2).
Factors Influencing Vaginal Dilator Use
Negative Emotions
More than half of the women expressed negative
emotions about dilator use. Experiencing pain,
blood loss, or discharge during dilator use made
half of the women anxious to use a dilator (Quote
5, Table 2), and a few were bothered by tension of
the pelvic floor muscles. Some had stopped dilator
use because of it. A couple of women indicated a
negative association with blood loss during dilator
use, or sexual contact, and cancer (fear of recur-
rence). Women acknowledged that dilator use
confronted them with the fact that they were still
dealing with the cancer. Also, some women nega-
tively associated dilator insertion with the invasive
brachytherapy treatment, or were not ready for
dilator use yet (Quote 6, Table 2). Almost half of
the women acknowledged that regular dilator use
felt like homework or a bothersome chore (Quote
7, Table 2). Also, some women felt resistant or
even repulsed toward dilator use. A few women felt
so repulsed that they stopped dilator use. Lastly, a
few women stated not being the type to perform
dilator use as if it embarrassed them.
Resources
A couple of women were frustrated about their
health insurance company not paying for the
dilator set (as one of the two hospitals itself did not
supply them) (Quote 8, Table 2) or having to buy
neutral (water- or silicone-based) lubricants them-
selves. One older woman stated being embarrassed
by having to explain at her local drugstore why
she would need lubricants. Informational support
from health care providers reassured some women
that it was normal experiencing certain setbacks
during dilator use, such as blood loss (Quote 9,
Table 2). However, some women stated to lack
professional advice or support and therefore did
not use a dilator more often. Another woman
regretted not getting more follow-up appoint-
ments with her helpful oncology nurse. Several
women suggested that it would be helpful to have
at least one consult with a psychologist or other
health care provider to support them with dilator
use at the end or just after treatment.
A few women mentioned being supported
socially and received encouragement to continue
from their partner, friends, or health care provider
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(Quote 10, Table 2). Most partnered women did
not involve their partner in dilator use. However,
a few women felt supported and experienced less
anxiety by doing so. Also, a few mentioned their
partner remembering more of the received instruc-
tions regarding vaginal dilator use than they did.
Perceived Self-Efficacy of Vaginal Dilator Use
A few women acknowledged that it was not the
action itself that was hard to achieve, but that other
barriers (such as negative emotions) made it hard
to perform regular dilator use. Another few men-
tioned doubting that dilator insertion was physi-
cally possible. A few women expressed not being
able to build dilator use into their routine (Quote
11, Table 2). Whereas a few participants men-
tioned that dilator use made them feel in control of
the prevention of adhesions.
Importantly, someone indicated that experienc-
ing pain during dilator use made her not want to
have sexual intercourse anymore. Nevertheless, a
few women indicated that dilator use helped them
to initiate sexual intercourse, because it made them
aware that it was physically possible without a lot
of pain and therefore reduced anxiety.
Dilator Design
More than half of the women had negative feelings
about the (“hard and clinical”) design of the plastic
dilator set. Besides, some women desired a more
pleasurable dilator made out of softer material;
a few women mentioned a dilator should have
a bigger diameter, a (nontransparent) color, be
pointier, or able to rotate itself. Others wanted a
more pleasurable design that would be suitable to
integrate in sexual contact. Half of the women
rather saw dilators as a technical tool or medical
device. Therefore, some added that its neutral
design is appropriate. Also, a group of women sug-
gested it was not necessary to provide a dilator set
containing four sizes. Some women never used the
smallest size, because according to them, it did not
serve a purpose. Whereas others never used the
biggest size, because it was too painful and the
doctor told them that using this size was not nec-
essary to prevent adhesions.
Discussion
This study distinguished determinants of the
intention, initiation, and maintenance of dilator
use. Almost all women intended and attempted
to perform long-term regular vaginal dilator use.
The intention to perform dilator use was deter-
mined by the motivation to prevent the develop-
ment of vaginal adhesions and stenosis, with the
expectation that it would keep the vagina acces-
sible. The intention was influenced by the quality
and quantity of instructions, the degree to
which dilator use was evaluated during follow-up
appointments, and experienced benefits. Women
reported planning dilator use and made it part of a
routine, used lubricants or vibrators, or performed
dilator use under the shower. Others had difficul-
ties planning dilator use and reported a lack of
time or privacy, forgetting, and feeling tired when
performing dilator use. Women regulated dilator
use by rotating the dilator and timing dilator use.
Influencing factors were negative emotions about
dilator use, pain or blood loss during dilator
use, and the association with brachytherapy.
Some women mentioned a lack of instrumental
resources. Others were helped by informational or
social support.
The reported determinants of dilator use
confirm the limiting and facilitating factors that
were previously described [23,24]. The represen-
tativeness of the study population might be
limited, because women with insufficient knowl-
edge of the Dutch language were excluded from
participation. Also, women that feared to talk
about the subject or had great resistance toward
dilator use might have declined participation more
often. Therefore, it is possible that this study’s
population was more motivated to use dilators
compared with an average patient. However,
almost all participants were diagnosed with cervi-
cal cancer and two-thirds had a sexual relationship.
Therefore, the selected participants did represent
the target group that receives EBRT/BT and the
recommendation to perform long-term regular
dilator use.
A few partnered women indicated that dilator
use had beneficial effects regarding sexual inter-
course. It makes sense that having a satisfactory
sexual intercourse might be an important incentive
for long-term regular dilator use. In this study,
compliant participants did not mention to be more
sexually active or satisfied, nor did they seem to
differ in relationship status. It is, however, inter-
esting to investigate whether sexual behavior could
influence dilator use in a prospective (quantitative)
study.
Women mentioned the dilator design to be
relevant for their dilator use behavior. In the
Netherlands, white or transparent plastic dilator
sets are advised. However, in other countries,
different dilator sets might be used. It is not known
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whether women would have adhered to long-term
regular dilator use when their health care provid-
ers discussed or demonstrated different dilator
sets. It is important to provide women with alter-
native types of dilators, such as vibrators, when
possible and to let the patient decide on which
type of dilator to use [29] (see Table 3 for more
recommendations).
In order to effectively support women with
dilator use, interventions should match whether
women need help with the intention formation,
initiation, or maintenance of dilator use. Accord-
ing to Schwarzer et al., women with no intention
can be expected to benefit from the confrontation
or learning experience that regular dilator use has
positive outcomes [25]. This was confirmed by the
reported influence of the quantity and quality of
received instructions, dilator use evaluation, and
experienced benefits on participants’ intention to
start or continue dilator use. Previous studies also
described that information provision can help
women adhere (see Table 3) [18,20,22,29,31,32].
Some participants reported that they were not
readily able to use dilators because of anxieties or
other barriers. However, participants’ perceived
self-efficacy to maintain dilator use, or to resume
after discontinuing dilator use, was hardly sponta-
neously discussed. The HAPA constructs were not
part of the interview guideline and it remains
unclear whether participants saw themselves as
capable of long-term regular dilator use. Because
almost all participants at least attempted dilator
use but only part of them continued, the main
challenge appears to be to increase long-term
regular adherence among women. According to
participants in the current study, women could
benefit from planning, and preparing for situations
in which they tend to stop using dilators is immi-
nent. Therefore, also in concordance with the
HAPA [25], interventions should help this group
Table 3 Recommendations for health care providers regarding the intention formation, initiation, or maintenance of
patients’ vaginal dilator use
The intention to start dilator use
Provide explanation and/or learning experience regarding risk of vaginal adhesions and positive outcomes of dilator use
• Provide clear rationale that dilator use:
— Prevents the formation of vaginal adhesions
— Keeps the vagina accessible for penetration (in the future; for women without partner)
— Also makes future vaginal examination during follow-up appointments more convenient
— Can be useful to help reduce fear for bodily changes and sexual activity
• Provide clear instructions (regarding the frequency, duration [minutes], period of dilator use [months], how to insert) and
psycho-education regarding dilator use through oral information, a specific information brochure, and/or websites
• Discuss and consider demonstrating various types of dilators (e.g., commercially available plastic dilator sets, softer dilators, vibrators)
and let the patient ultimately decide
• Provide a dilator set or specific recommendations after discussing options.
• Encourage that inserting a dilator vaginally is physically possible after treatment
The initiation and maintenance of dilator use
Help to plan and control dilator use
• Encourage gradually increasing the dilator size that is used, once a smaller size is used without difficulty
• Encourage building dilator use into a routine (on convenient time and fixed days during the week)
• Help to time dilator use, e.g., by setting a clock
• Advise to guarantee privacy during dilator use
• Advise to find comfortable position in bed or under the shower
• Advise to place dilator against vaginal opening first in order to reduce anxiety
Provide support
• Monitor and evaluate dilator use during every follow-up appointment
• Emphasize experienced benefits while evaluating dilator use
• Involve women’s partners during consultations depending on the patient’s needs
• Actively involving the partner during dilator use itself should depend on the patient’s needs
• Extra consultations with a specialized oncology nurse, psychologist, or sexologist should be made possible
Help to prepare for situations in which women tend to stop dilator use
• Recommend using lubricants to prevent painful experiences; discuss various types of lubricants and their specific properties
• Give simple advice, such as how to relax the pelvic floor muscles
• Provide reassurance that dilator use might feel uncomfortable or painful, or may cause minor blood loss or vaginal discharge
Help to deal with negative emotions, behavioral skills, and motivational issues
• Challenge women’s resistance, repulsion, embarrassment, and other negative emotions regarding dilator use by using cognitive
behavioral therapeutic techniques
• Explore and resolve patients’ ambivalence and lack of self-efficacy regarding dilator use (i.e., motivational interviewing counseling
approach may be helpful)
• Fear of dilator use may be reduced during a health care provider-guided dilator use practicing session at the hospital
• Refer women to a sexologist in case simple sexological advice does not suffice
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of women change their routine and negative
emotions about dilator use or enlarge their per-
ceived self-efficacy. Such a supportive intervention
could comprise a short cognitive behavioral
therapy intervention and apply motivational inter-
viewing [33] to help women deal with behavioral
skills and motivational issues [18,20]. Specialized
nurses could provide this after EBRT/BT [31].
Furthermore, participants mentioned that social
support was helpful. This confirms previous
results that including partners or a peer group in
such an intervention is beneficial as well (see
Table 3) [20,34].
Conclusion
In the current study, useful motivation and volition
processes that determined initiation and mainte-
nance of dilator use were identified. These and the
principles discussed above were used in the devel-
opment of a sexual rehabilitation intervention for
gynecological cancer patients, which is currently
pilot-tested.
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